|
Neonatal Intensive Care Drug Manual
|
| bet | 632/654 | | Sana | 03.01.2022 | | Hajmi | 1,5 Mb. | | #14803 |
Practice points
|
|
References
|
Pacifici GM, Allegaert K. Clinical pharmacokinetics of vancomycin in the neonate: a review. Clinics. 2012;67:831-7.
Bhongsatiern J, Stockmann C, Roberts JK, Yu T, Korgenski KE, Spigarelli MG, Desai PB, Sherwin CM. Evaluation of Vancomycin Use in Late-Onset Neonatal Sepsis Using the Area Under the Concentration-Time Curve to the Minimum Inhibitory Concentration >=400 Target. Ther Drug Monit. 2015;37:756-65.
Kato H, Hagihara M, Nishiyama N, Koizumi Y, Mikamo H, Matsuura K, Yamagishi Y. Assessment of optimal initial dosing regimen with vancomycin pharmacokinetics model in very low birth weight neonates. J Infect Chemother. 2017;23:154-60.
Kim J, Walker SA, Iaboni DC, Walker SE, Elligsen M, Dunn MS, Allen VG, Simor A. Determination of vancomycin pharmacokinetics in neonates to develop practical initial dosing recommendations. Antimicrob Agents Chemother. 2014;58:2830-40.
Gwee A, Cranswick N, McMullan B, Perkins E, Bolisetty S, Gardiner K, Daley A, Ward M, Chiletti R, Donath S, Hunt R. Continuous Versus Intermittent Vancomycin Infusions in Infants: A Randomized Controlled Trial. Pediatrics. 2019 Feb 1;143(2):e20182179..
Clinical Excellence Commission, 2018, Newborn Antibiotic Guideline for early and late onset sepsis during birth episode of care. Revised June 2018. Sydney: Clinical Excellence Commission.
Clinical Excellence Commission, 2018, Paediatric Antibiotic Guidelines for Severe Sepsis & Septic Shock & Unwell Neonates. Revised July 2018. Sydney: Clinical Excellence Commission.
Ceriani Cernadas JM, Fernandez Jonusas S, Marquez M, Garsd A, Mariani G. Clinical outcome of neonates with nosocomial suspected sepsis treated with cefazolin or vancomycin: a non-inferiority, randomized, controlled trial. Arch Argent Pediatr. 2014;112:308-14.
Deville JG, Adler S, Azimi PH, Jantausch BA, Morfin MR, Beltran S, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB. Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates. Pediatr Infect Dis J. 2003;22:S158-63.
Shah SS, Ohlsson A, Shah VS. Intraventricular antibiotics for bacterial meningitis in neonates. Cochrane Database Syst Rev. 2012.
Arnell K, Enblad P, Wester T, Sjolin J. Treatment of cerebrospinal fluid shunt infections in children using systemic and intraventricular antibiotic therapy in combination with externalization of the ventricular catheter: efficacy in 34 consecutively treated infections. J Neurosurg. 2007;107:213-9.
Jardine LA, Inglis GDT, Davies MW. Prophylactic systemic antibiotics to reduce morbidity and mortality in neonates with central venous catheters. Cochrane Database Syst Rev. 2008.
Baier RJ, Bocchini JA, Jr., Brown EG. Selective use of vancomycin to prevent coagulase-negative staphylococcal nosocomial bacteremia in high risk very low birth weight infants. Pediatr Infect Dis J. 1998;17:179-83.
Kacica MA, Horgan MJ, Ochoa L, Sandler R, Lepow ML, Venezia RA. Prevention of gram-positive sepsis in neonates weighing less than 1500 grams. J Pediatr. 1994;125:253-8.
Moller JC, Nelskamp I, Jensen R, Reiss I, Kohl M, Gatermann S, Iven H, Gortner L. Comparison of vancomycin and teicoplanin for prophylaxis of sepsis with coagulase negative staphylococci (CONS) in very low birth weight (VLBW) infants. J Perinat Med. 1997;25:361-7.
Shah D, Sinn JKH. Antibiotic regimens for the empirical treatment of newborn infants with necrotising enterocolitis. Cochrane Database Syst Rev. 2012.
Bury RG, Tudehope D. Enteral antibiotics for preventing necrotizing enterocolitis in low birthweight or preterm infants. Cochrane Database Syst Rev. 2001.
Siu YK, Ng PC, Fung SC, Lee CH, Wong MY, Fok TF, So KW, Cheung KL, Wong W, Cheng AF. Double blind, randomised, placebo controlled study of oral vancomycin in prevention of necrotising enterocolitis in preterm, very low birthweight infants. Arch Dis Child Fetal Neonatal Ed. 1998;79:F105-9.
Australian Injectable Drugs Handbook 7th Edition - AIDH (Australian I.V. Medicines) Accessed 06/12/2018.
Micromedex online. Accessed 06/12/2018.
Aronoff GR, Bennett WM, Berns JS, et al, Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children, 5th ed. Philadelphia, PA: American College of Physicians; 2007, 154.
Brown DL, Lalla CD, Masselink AJ. AUC versus peak-trough dosing of vancomycin: applying new pharmacokinetic paradigms to an old drug. Ther Drug Monit. 2013; 35:443-9.
de Hoog M, Mouton JW, van den Anker JN. Vancomycin: pharmacokinetics and administration regimens in neonates. Clinical Pharmacokinetics. 2004; 43:417-40.
Roberts JK, Stockmann C, Constance JE, Stiers J, Spigarelli MG, Ward RM, Sherwin CMT. Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants. Clinical Pharmacokinetics. 2014;53:581-610.
Marsot A, Boulamery A, Bruguerolle B, Simon N. Vancomycin: a review of population pharmacokinetic analyses. Marsot A, Boulamery A, Bruguerolle B, Simon N. Vancomycin: a review of population pharmacokinetic analyses. Clin Pharmacokinet. 2012;51:1-13. Clin Pharmacokinet. 2012;51:1-13.
MIMS Australia online. Accessed on 14 January 2020.
Zane NR, Reedy MD, Gastonguay MR, Himebauch AS, Ramsey EZ, Topjian AA, et al. A Population pharmacokinetic analysis to study the effect of therapeutic hypothermia on vancomycin disposition in children resuscitated from cardiac arrest. Pediatric Critical Care Medicine. 2017;18(7):e290-e7.
|
Original version Date: 8/8/2015
|
Author: NMF Consensus Group
|
Current Version number: 9
|
Current Version Date: 16/11/2020
|
Risk Rating: Low
|
Due for Review: 16/11/2025
|
Approval by: DTC
|
Approval Date: TBA
|
|
| |
